Ingmar joined Brandon Capital Partners in 2009.
Previously, Ingmar was at Melbourne Ventures, commercialising technologies from The University of Melbourne. Before this he worked for Sanofi, in France, in particular in the Cardiovascular Franchise of Global Marketing on Plavix, which during this time grew to be the 2nd-biggest selling drug in the world. Earlier he worked with Boston Consulting Group and several health-related start-up companies. He began his professional career as a medical doctor, spending several years in clinical medicine.
Ingmar is currently a director of; Athena Medicines, Cardiora, Denteric and PolyActiva.
Ingmar has a Bachelor of Medicine, Bachelor of Surgery from The University of Melbourne and an MBA from Melbourne Business School. Ingmar is a graduate of the Australian Institute of Company Directors.